Best Alcohol and Drug Rehab NJ in Port Reading, NJ

Jeffrey A. Berman, MD, FASAM is a Diplomate and Fellow of the American Society of Addiction Medicine. He is the Executive Medical Director of Discovery Institute for Addictive Disorders in Marlboro, NJ and Clinical Assistant Professor of Psychiatry at the Robert Wood Johnson Medical School. He was recruited from Bergen Regional Medical Center, NJ’s largest acute psychiatric hospital, where he served as Director of Chemical Dependency Services to join Discovery Institute in Marlboro. Dr. Berman is a diplomate of the American Board of Psychiatry and Neurology (ABPN) in Adult and Addiction Psychiatry as well as Psychosomatic Medicine. He has been certified by the American Society of Addiction Medicine since 1988 and is Board Certified in Addiction Medicine (ABAM). Dr. Berman’s area of special interest in research and teaching is Pain Management and Co-occurring Opioid Dependence. He is also a strong advocate for Medication Assisted Treatment (MAT) for the chronic persistent mentally ill. Dr. Berman participated in NIDA’s clinical trials of Buprenorphine/Naloxone for treatment of heroin addiction in 2001. Since then he has developed innovative treatment programs for individuals with Co-occurring disorders as well as Substance Use Disorders. Dr. Berman served as Chief of Psychiatry at Fort Leavenworth, KS including the Department of Defense’s US Disciplinary Barracks located at Fort Leavenworth. He recently retired from the US Army Reserve after 22 years of service which included service in Operations Desert Storm and Iraqi Freedom. He is currently the Psychiatric Consultant to the Department of Immigration Health (DIHS), a division of Homeland security. Prior to coming to New Jersey, he served as Medical Director of Gieisinger Health Care’s Marworth chemical dependency center and consultant to pain management centers in New Jersey and Pennsylvania for issues of addiction, pain and co-occurring mood disorders. He has taken an active role in the medical treatment of HIV patients in all of these clinical settings.

Crystal brings to Lighthouse a strong passion for addiction, education, and mental health. She hopes to utilize her leadership role as Clinical Director to help enhance clinical programming and therapeutic techniques to get that much closer to RCA’s mission of saving one million lives. Upon completing her Master’s degree from Rosemont College, she immediately followed her heart and found her passion for addiction in 2013. Crystal has worked in several different levels of care, however found her home when she came to RCA in 2017. Since coming to RCA, Crystal has held several roles beginning as an outpatient therapist, inpatient therapist, supervisor and now Director. Crystal has extensive knowledge in substance use and co-occurring disorders. She particularly enjoys working with individuals with identified trauma, co-occurring issues, as well as has a special interest in the study of eating disorders. As the Clinical Director, Crystal oversees daily programming and assist in development of continued enhancements, helps manage day-to-day responsibilities and functions, as well as is a part of the growth process for the clinical team. Crystal believes that being a great director reflects in those growing around you and that is what she strives for daily. Crystal’s greatest pleasure is having the opportunity to work alongside passionate and caring individuals. Working in the field, such as addiction can be hard at times, however Crystal believes in RCA’s mission and strives to provide the utmost dignity, respect, and compassion for all clients that come to treatment. Crystal stands by the saying, “they say if you love what you do, you never work a day in your life.” With this company and Team, she believes that couldn’t be more true. Each day is an honor and a privilege. Crystal cannot wait to see how many more lives we save and how much more we grow.

William D Stanley, born and raised in Baltimore, MD, attended UMDNJ-Robert Wood Johnson Medical school. Later, he did his internship and residency at Albert Einstein Med Center in Philadelphia. Initially, he practiced primary care for many years but due to the influence of many people—in particular, Dr. Lou Baxter—his eyes gravitated to the world of substance abuse. Dr. Stanley became certified by the American Board of Addiction Medicine in 2000. He initially focused on outpatient treatment of opioid dependence with Suboxone and, more recently, Vivitrol. He was invited to join the family of Summit Behavioral Health in 2013 part-time and started full-time as the medical director of their detox in December 2014.